These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tyramine and new monoamine oxidase inhibitor drugs. Simpson GM, de Leon J. Br J Psychiatry Suppl; 1989 Oct 17; (6):32-7. PubMed ID: 2695125 [Abstract] [Full Text] [Related]
4. On combining TCAs and MAOIs. Grounds D. Aust N Z J Psychiatry; 1993 Jun 17; 27(2):344, 346. PubMed ID: 8363548 [No Abstract] [Full Text] [Related]
5. Combined MAOI-tricyclic antidepressant treatment: a reply to Dr. Davidson. White K, Simpson G. J Clin Psychopharmacol; 1982 Aug 17; 2(4):286-7. PubMed ID: 7119138 [No Abstract] [Full Text] [Related]
6. [MAO inhibitors and depressive disorders today]. Bonamy D, Olié JP, Lôo H. Encephale; 1983 Aug 17; 9(2):123-36. PubMed ID: 6641614 [Abstract] [Full Text] [Related]
7. Monoamine oxidase inhibitors--current status. Zemishlany Z, Radwan M, Wijsenbeek H. Isr J Psychiatry Relat Sci; 1983 Aug 17; 20(3):254-71. PubMed ID: 6325369 [No Abstract] [Full Text] [Related]
13. Monoamine oxidase inhibitors. Lippmann S. Am Fam Physician; 1986 Jul 17; 34(1):113-9. PubMed ID: 3728254 [Abstract] [Full Text] [Related]
14. A clinical overview of monoamine oxidase inhibitors. Zisook S. Psychosomatics; 1985 Mar 17; 26(3):240-6, 251. PubMed ID: 3887453 [No Abstract] [Full Text] [Related]
15. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy. Tiller JW, Mitchell P, Burrows GD. Aust N Z J Psychiatry; 1992 Jun 17; 26(2):327-9. PubMed ID: 1642632 [No Abstract] [Full Text] [Related]
16. Which antidepressant? Benaim S. Br J Clin Pract; 1990 May 17; 44(5):196-200. PubMed ID: 2390444 [No Abstract] [Full Text] [Related]
17. Combined use of TCAs and MAOIs. Stewart JW. Psychosomatics; 1985 Nov 17; 26(11):879. PubMed ID: 4080936 [No Abstract] [Full Text] [Related]
18. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art. Rapaport MH. J Clin Psychiatry; 2007 Nov 17; 68 Suppl 8():42-6. PubMed ID: 17640157 [Abstract] [Full Text] [Related]
19. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression. Adli M, Pilhatsch M, Bauer M, Köberle U, Ricken R, Janssen G, Ulrich S, Bschor T. Pharmacopsychiatry; 2008 Nov 17; 41(6):252-7. PubMed ID: 19067263 [Abstract] [Full Text] [Related]